Drug Shortage Report for JANUMET XR

Last updated on 2022-05-24 History
Report ID 157340
Drug Identification Number 02416794
Brand name JANUMET XR
Common or Proper name sitagliptin and metformin hydrochloride modified-release tablets
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 1000MG 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2022-06-06
Actual start date
Estimated end date 2022-06-13
Actual end date 2022-05-24
Shortage status Avoided shortage
Updated date 2022-05-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-05-24 French Compare
v11 2022-05-24 English Compare
v10 2022-05-05 French Compare
v9 2022-05-05 English Compare
v8 2022-04-18 French Compare
v7 2022-04-18 English Compare
v6 2022-04-12 French Compare
v5 2022-04-12 English Compare
v4 2022-04-11 French Compare
v3 2022-04-11 English Compare
v2 2022-03-25 French Compare
v1 2022-03-25 English Compare

Showing 1 to 12 of 12